Quetiapine and essential tremor

Clinical Neuropharmacology

Volumn 25, Issue 6, 2002, Pages 303-306

  Micheli, Federico ^a   Cersósimo, María Graciela ^a   Raina, Gabriela ^a   Gatto, Emilia ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Antipsychotic drugs; Essential tremor; Quetiapine

Indexed keywords

CLONAZEPAM; CLOZAPINE; DOPAMINE 1 RECEPTOR; PHENOBARBITAL; PRIMIDONE; PROPRANOLOL; QUETIAPINE;

ADULT; AGED; ANGER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; DRUG SAFETY; DRUG TOLERABILITY; ESSENTIAL TREMOR; FEMALE; HALLUCINATION; HUMAN; MALE; OPEN STUDY; PRIORITY JOURNAL; SOMNOLENCE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0036869503     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200211000-00004     Document Type: Article

References (25)

1. Brin MF, Koller W. Epidemiology and genetics of essential tremor. Mov Disord 1998;13(suppl 3):55-63.
2. Deuschl G, Elble RJ. The pathophysiology of essential tremor. Neurology 2000;54(suppl 4):S14-S20.
3. Koller WC, Gupta S. Pharmacologic probe with progabide of GABA mechanism in essential tremor. Arch Neurol 1987;44:905-7.
4. Koller WC. Trazodone in essential tremor. Probe of serotoninergic mechanisms. Clin Neuropharm 1987;12:134-7.
5. Evidente VGH. Understanding essential tremor. Postgrad Med 2000;108:138-49.
6. Koller WC, Hristova A, Brin M. Pharmacologic treatment of essential tremor. Neurology 2000;54(suppl 4):S30-S38.
7. Galvez-Jimenez N, Hargreave M. Topiramate and essential tremor. Ann Neurol 2000;47:837-38.
8. Louis ED. Clinical practice: Essential tremor. N Engl J Med 2001; 345:887-91.
9. Friedman JH, Lannon MC. Clozapine-responsive tremor in Parkinson's disease. Mov Disord 1990;5:225-29.
10. Bonnuccelli U, Ceravolo R, Salvetti S, et al. Clozapine in Parkinson's disease tremor. Neurology 1997;49:1587-90.
11. Ceravolo R, Salvetti S, Piccini P, et al. Acute and chronic effects of clozapine in essential tremor. Mov Disord 1999;14:468-72.
12. Factor SA, Friedman JH. The emerging role of clozapine in the treatment of movement disorders. Mov Disord 1997;4:483-96.
13. Dev V, Raniwalla J. Quetiapine: A review of its safety in the management of schizophrenia. Drug Saf 2000;23:295-307.
14. Worrel JA, Marken PA, Beckman SE, et al. Atypical antipsychotic agents: A critical review. Am J Health Syst Pharm 2000;57:238-55.
15. Meltzer HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999;21(suppl 2):106S-115S.
16. Misra LK, Erpenbach JE, Hamlyn H, et al. Quetiapine: A new atypical antipsychotic. S D J Med 1998;51:189-93.
17. Dewey RB Jr, O'Suilleabhain PE. Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease. Neurology 2000;55:1753-54.
18. Deustchl G, Bain P, Brin M, et al. Consensus statement of the Movement Disorder Society on Tremor. Mov Disorder 1998;13(suppl 3): 2-23.
19. Louis ED, Ottman R, Ford B, et al. The Washington Heights-Inwood Genetic Study of Essential Tremor: Methodologic issues in essential-tremor research. Neuroepidemiology 1997;16: 124-33.
20. Koller WC, Pahwa PR, Lyons KE, et al. Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor. Neurology 2000;55(suppl 6):S29-S33.
21. Menza MM, Palermo B, Mark M. Quetiapine as an alternative to clozapine in the treatment of dopaminergic psychosis in patients with Parkinson's disease. Ann Clin Psychiatry 1999;11:141-44.
22. Saller CF, Salama AI. Seroquel: Biochemical profile of a potential atypical antipsychotic. Psychopharmacology (Berl) 1993;112: 285-92.
23. Dev V, Raniwalla J. Quetiapine: A review of its safety in the management of schizophrenia. Drug Saf 2000;23:295-307.
24. Glassman AH, Bigger JT Jr. Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001;158:1774-82.
25. Teravainen H, Huttunen J, Larsen TA. Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremor. Acta Neurol Scand 1986;74:34-37.